| Company Name | Bayer Taiwan Co., Ltd. |
|---|---|
| Protocol Number | 16657 |
| Title of Study | EXPERT, EXPosurE Registry RiociguaT in patients with pulmonary hypertension |
| Primary Objective | The primary objective is the assessment of long-term safety of Adempas® in real life clinical practice. |
| Number of Sites | 8 |
| Period of Study | From：10/06/2016 to：Ongoing |
| Number of Patients | 50人 |
| IRB Approval Date | 成大醫院 NCKUH:04/29/2016 台大NTUH:07/20/2016 高榮VGH-KS:08/09/2016 馬偕MMH:07/05/2016 北榮VGH-TP:07/29/2016 高醫KMUH:07/22/2016 振興CHGH:08/10/2016 林長CGMH-LK:11/01/2016 |
| Publication Plan / Date | Unknown/未知 |
